Exploration of biological markers of suicidal behavior in major depressive disorder

Psychiatry Investigation

Volumn 4, Issue 1, 2007, Pages 13-21

  Kim, Yong Ku ^a   Won, Sung Doo ^a   Hur, Ji Won ^a   Lee, Bun Hee ^a   Lee, Hwa Young ^a   Shim, Se Hoon ^b   Han, Sang Woo ^b   Choi, So Hyun ^c  

^a Korea University   (South Korea)

^b Soonchunhyang University   (South Korea)

^c Yongin Mental Hospital   (South Korea)

Author keywords

Brain derived neurotrophic factor (BDNF); Cytokine; Depression; Insulin like growth factor (IGF); Nerve growth factor (NGF); Nitric oxide; Suicide

Indexed keywords

BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; NERVE GROWTH FACTOR BETA SUBUNIT; NITRIC OXIDE; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; PROTEIN BLOOD LEVEL; RISK FACTOR; SUICIDAL BEHAVIOR; SUICIDE ATTEMPT;

EID: 34247195070     PISSN: 17383684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (75)

1. Alvarez JC, Cremniter D, Gluck N, Quintin P, Leboyer M, Berlin I, et al. Low serum cholesterol in violent but not in non-violent suicide attempters. Psychiatry Res 2000;95:103-108.
2. APA. Diagnostic and statistical manual of mental disorders (4rd ed). Washington: American Psychiatric Press, 1994.
3. Arango V, Underwood MD, Gubbi AV, Mann JJ. Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res 1995;688:121-133.
4. Berman AL, Shepherd G, Silverman MM. The LSARS-II: lethality of suicide attempt rating scale-updated. Suicide Life Threat Behav 2003;33:261-276,
5. Bernstein HG, Stanarius A, Baumann B, Henning H, Krell D, Danos P, et al. Nitric oxide synthase-containing neurons in human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics. Neuroscience 1998;83: 867-875.
6. Brent DA, Bridge J, Johnson BA, Connolly J. Suicidal behavior runs in families. A controlled family study of adolescent suicide victims. Arch Gen Psychiatry 1996;53:1145-1152.
7. Carlson KW, Nawy SS, Wei ET, Sadee W, Filov VA, Rezsova VV, et al. Inhibition of mouse melanoma cell proliferation by corticotropin-releasing hormone and its analogs. Anticancer Res 2001;21:1173-1179.
8. Chrapko WE, Juracs P, Radomski MW, Lara N, Archer S, Le Melledo JM. Decreased plasma nitric oxide metabolites and platelet nitric oxide synthase activity in patients with major depression. Biol Psychiatry 2004;56:129-134.
9. Colin A, Reggers J, Castronovo V, Ansseau M. Lipids, depression and suicide. Encephale 2003;29:49-58.
10. Cooper SJ, Kelly CB, King DJ. 5-Hydroxyindoleacetic acid in cerebrospinal fluid and prediction of suicidal behavior in schizophrenia. Lancet 1992;340:940-941.
11. Coryell W, Schlesser M. The dexamethasone suppression test and suicide prediction. Am J Psychiatry 2001;158:748-753.
12. Cremniter D, Jamain S, Kollenbach K, Alvarez JC, Lecrubier Y, Gilton A, et al. CSF 5-HIAA levels are lower in impulsive as compared to nonimpulsive violent suicide attempters and control subjects. Biol Psychiatry 1999;45:1572-1579.
13. De Groote D, Zangerle PF, Gevaert Y, Fassotte MF, Beguin Y, Noizat-Pirenne F, et al. Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine 1992;4:239-248.
14. Duman RS, Heninger GR, Nestler EJ. A molecular and cellular theory of depression. Arch Gen Psychiatry 1997;54:597-606.
15. Dwivedi Y, Mondal AC, Rizavi HS, Conley RR. Suicide brain is associated with decreased expression of neurotrophins. Biol Psychiatry 2005;58:315-324.
16. Dwivedi Y, Rizavi HS, Conley RR, Roberts RC, Tamminga CA, Pandey GN. Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry 2003;60:804-815.
17. Fiddler RN. Collaborative study of modified AOAC method of analysis for nitrite in meat and meat products. J Assoc Off Anal Chem 1977;60:594-599.
18. Frisch C, Dere E, Silva MA, Godecke A, Schrader J, Huston JP. Superior water maze performance and increase in fear-related behavior in the endothelial nitric oxide synthase-deficient mouse together with monoamine changes in cerebellum and ventral striatum. J Neurosci 2000;20:6694-6700.
19. Gadient RA, Otten U. Expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat brain during postnatal development. Brain Res 1994;637:10-14.
20. Gadient RA, Orten UH. Interleukin-6 (IL-6) -a molecule with both beneficial and destructive potentials. Prog Neurobiol 1997;52:379-390.
21. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
22. Harvey BH, Oosthuizen F, Brand L, Wegener G, Stein DJ. Stress-re-stress evokes sustained iNOS activity and altered GABA levels and NMDA receptors in rat hippocampus. Psychopharmacology (Berl) 2004;174:494-502.
23. Jozuka H, Jozuka E, Suzuki M, Takeuchi S, Takatsu Y. Psycho-neuro- immunological treatment of hepatocellular carcinoma with major depression-a single case report. Curr Med Res Opin 2003;19:59-63.
24. Kamali M, Oquendo MA, Mann JJ. Understanding the neurobiology of suicidal behavior. Depress Anxiety 2001;14:164-176.
25. Kapur S, Mann JJ. Role of the dopaminergic system in depression. Biol Psychiatry 1992;32:1-17.
26. Karege F, Vaudan G, Schwald M, Perroud N, La Harpe R. Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Brain Res Mol Brain Res 2005;136:29-37.
27. Kim YK, Lee HJ, Kim JY, Yoon DK, Choi SH, Lee MS. Low serum cholesterol is correlated to suicidality in a Korean sample. Acta Psychiatr Scand 2002;105:141-148.
28. Kim YK, Maes M. The role of cytokine network in psychological stress. Acta Neuropsychiatrica 2003;15:148-155.
29. Kim YK, Myint AM. Clinical application of low serum cholesterol as an indicator for suicide risk in major depression. J Affect Disord 2004; 81:161-166.
30. Kim YK, Paik JW, Lee SW, Yoon D, Han C, Lee BH. Increased plasma nitric oxide level associated with suicide attempt in depressive patients. Prog Neuropsychopharmacol Biol Psychiatry 2006;30:1091-1096.
31. Kim YK, Suh IB, Kim H, Han CS, Lim CS, Choi SH, et al. The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs. Mol Psychiatry 2002; 7:1107-1114.
32. Lee HJ, Kim YK. Serum lipid levels and suicide attempts. Acta Psychiatr Scand 2003;108:215-221.
33. Leonard BE. Changes in the immune system in depression and dementia: causal or co-incidental effects? Int J Dev Neurosci 2001;19:305-312.
34. Lewin GR, Barde YA. Physiology of the neurotrophins. Annu Rev Neurosci 1996;19:289-317.
35. Madrigal JL, Moro MA, Lizasoain I, Lorenzo P, Castrillo A, Bosca L, et al. Inducible nitric oxide synthase expression in brain cortex after acute restraint stress is regulated by nuclear factor kappa B-medicated mechanisms. J Neurochem 2001;76:532-538.
36. Madrigal JL, Moro MA, Lizasoain I, Lorenzo P, Fernandez AP, Rodrigo J, et al. Induction of cyclooxygenase-2 accounts for restrain stress-induced oxidative status in rat brain. Neuropsychopharmacology 2003;28:1579-1588.
37. Maes M. Major depression and activation of the inflammatory response system. Adv Exp Med Biol 1999;461:25-46.
38. Malberg JE, Eisch AJ, Nestler EJ, Duman RS. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 2000;20:9104-9110.
39. Mann JJ. The neurobiology of suicide. Nat Med 1998;4:25-30.
40. Mann JJ, Huang YY, Underwood MD, Kassir SA, Oppenheim S, Kelly TM, et al. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch Gen Psychiatry 2000;57:729-738.
41. Marazziti D, Presta S, Silvestri S, Battistini A, Mosti L, Balestri C, et al. Platelet markers in suicide attempters. Prog Neuropsychopharmacol Biol Psychiatry 1995;19:375-383.
42. Mattson MP, Maudsley S, Martin B. BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends Neurosci 2004;27:589-594.
43. Mendlovic S, Mozes E, Eilat E, Doron A, Lereya J, Zakuth V, et al. Immune activation in non-treated suicidal major depression. Immunol Lett 1999;67:105-108.
44. Miller DB, O'Callaghan JP. Depression, cytokines, and glial function. Metabolism 2005;54:33-38.
45. Miyazono K, Yuki K, Takaku F, Wernstedt C, Kanzaki T, Olofsson A, et al. Latent forms of TGF-beta: structure and biology. Ann N Y Acad Sci 1990;593:51-58.
46. Mizuno T, Sawada M, Suzumura A, Marunouchi T. Expression of cytokines during glial differentiation. Brain Res 1994;656:141-146.
47. Montague PR, Gancayco CD, Winn MJ, Marchase RB, Friedlander J. Role of NO production in NMDA receptor-mediated neurotransmitter release in cerebral cortex. Science 1994;263:973-977.
48. Myint AM, Kim YK. Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression. Med Hypotheses 2003; 61:519-525.
49. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. Neurobiology of depression. Neuron 2002;34:13-25.
50. Nordstrom P, Samuelsson M, Asberg M, Traskman-Bendz L, Aberg-Wistedt A, Nordin C, et al. CSF 5-HIAA predicts suicide risk after attempted suicide. Suicide Life Threat Behav 1994;24:1-9.
51. Ordway GA, Klimek V. Noradrenergic pathology in psychiatric disorders: postmortem studies. CNS Spectr 2001;6:697-703.
52. Pae CU, Yoon CH, Kim TS, Kim JJ, Park SH, Ue CU, et al. Antipsychotic treatment may alter T-helper (TH) 2 arm cytokines. Int Immunopharmacol 2006;6:666-671.
53. Penttinen J. Hypothesis: low serum cholesterol, suicide, and interleukin-2. Am J Epidemiol 1995;141:716-718.
54. Pfennig A, Kunzel HE, Kern N, Ising M, Majer M, Fuchs B, et al. Hypothalamus-pituitary-adrenal system regulation and suicidal behavior in depression. Biol Psychiatry 2005;57:336-342.
55. Prud'homme GJ, Piccirillo CA. The inhibitory effects of transforming growth factor-beta-1 (TGF-beta1) in autoimmune diseases. J Autoimmun 2000;14:23-42.
56. Roy A. Hypothalamic-pituitary-adrenal axis function and suicidal behavior in depression. Biol Psychiatry 1992;32:812-816.
57. Russo-Neustadt A, Ha T, Ramirez R, Kesslak JP. Physical activity-antidepressant treatment combination: impact on brain-derived neurotrophic factor and behavior in an animal model. Behav Brain Res 2001;120:87-95.
58. Schiepers OJ, Wichers MC, Maes M. Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:201-217.
59. Schmitt E, Hoehn P, Huels C, Goedert S, Palm N, Rude E, et al. T helper type 1 development of naive CD4+ T cells requires the coordinate action of interleukin-12 and interferon-gamma and is inhibited by transforming growth factor-beta. Eur J Immunol 1994;24: 793-798.
60. Schwarz MJ, Chiang S, Muller N, Ackenheil M. T-helper-1 and T-helper-2 responses in psychiatric disorders. Brain Behav Immun 2001; 15:340-370.
61. Sher L, Mann JJ, Traskman-Bendz L, Winchel R, Huang YY, Fertuck E, et al. Lower cerebrospinal fluid homovanillic acid levels in depressed suicide attempters. J Affect Disord 2006;190:83-89.
62. Smith K, Conroy RW, Ehler BD. Lethality of suicide attempt rating scale. Suicide Life Threat Behav 1984;14:215-242.
63. Smith MA, Makino S, Kvetnansky R, Post RM. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci 1995;15: 1768-1777.
64. Spitzer RL, Williams IB, Gibbon M, First MB. The Structured Clinical Interview for DSM-III-R (SClD). I: history, rationale, and description. Arch Gen Psychiatry 1992;49:624-629.
65. Thomas AJ, Davis S, Morris C, Jackson E, Harrison R, O'Brien JT. Increase in interleukin-1 beta in late-life depression. Am J Psychiatry 2005;162:175-177.
66. Traskman L, Asberg M, Bertilsson L, Sjostrand L. Monoamine metabolites in CSF and suicidal behavior. Arch Gen Psychiatry 1981;38: 631-636.
67. Tuglu C, Kara SH, Caliyurt O, Vardar E, Abay E. Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology (Berl) 2003;170:429-433.
68. van Heeringen K, Audenaert K, Van de Wiele L, Verstraete A. Cortisol in violent suicidal behaviour: association with personality and monoaminergic activity. J Affect Disord 2000;60:181-189.
69. Viljoen M, Panzer A. Proinflammatory cytokines: a common denominator in depression and somatic symptoms? Can J Psychiatry 2005;50: 128.
70. Weisman AD, Worden JW. Risk-rescue rating in suicide assessment. Arch Gen Psychiatry 1972;26:553-560.
71. Westling S, Ahren B, Traskman-Bendz L, Westrin A. High CSF-insulin in violent suicide attempters. Psychiatry Res 2004;129:249-255.
72. Xing G, Chavko M, Zhang LX, Yang S, Post RM. Decreased calcium-dependent constitutive nitric oxide synthase (cNOS) activity in prefrontal cortex in schizophrenia and depression. Schizophr Res 2002; 58:21-30.
73. Xu H, Qing H, Lu W, Keegan D, Richardson JS, Chlan-Fourney J, Li XM. Quetiapine attenuates the immobilization stress-induced decrease of brain-derived neurotrophic factor expression in rat hippocampus. Neurosci Lett 2002;321:65-68.
74. Yamada K, Noda Y, Nakayama S, Komori Y, Sugihara H, Hasegawa T, et al. Role of nitric oxide in learning and memory and in monoamine metabolism in the rat brain. Br J Pharmacol 1995;115:852-858.
75. Yerevanian BI, Feusner JD, Boek RJ, Mintz J. The dexamethasone suppression test as a predictor of suicidal behavior in unipolar depression. J Affect Disord 2004;83:103-108.